ÂÜÀòÂÒÂ×

Prakash Koodathingal is a seasoned professional in RNA therapeutic development and molecular biology, currently serving as the Director of RNA Therapeutic Development at Immunomic Therapeutics, Inc. since July 2022. With a distinguished career that includes roles such as Associate Director of Technical Development at Seqirus and Group Lead at GSK, Prakash has a strong background in mRNA vaccines and analytical development. Prior experience includes positions as Expert Scientist and Scientist-II at GSK, where focus encompassed process understanding and leading cross-functional teams. Academic credentials include a PhD in Biochemistry/Biotechnology from Central Drug Research Institute, India, and a Master of Science in Biotechnology from Tamil Nadu Agricultural University, India, along with extensive postdoctoral research at institutions such as The University of Chicago and Northwestern University. Prakash's research contributions include significant advancements in RNA analytics and virus-host interactions.